Since silicone breast implants have been re-introduced into the commercial marketplace in the United States in late 2006, most of the women seeking breast augmentation are not aware of the tremendous controversy with their predecessors fifteen years ago due to their age. Generally, only patients over the age of 40 would likely remember the tremendous publicity that surrounded silicone breast implants being banned by the FDA at that time.

They identified five such publications and reviewed them in detail in the article. In none of the studies were diseases or symptoms related to some form of connective tissue disease associated with breast implant rupture status. No credible evidence can be found that would support the concept of a ‘silicone-related disorder’ exists amongst breast implant patients, particularly those whose implants are known to be ruptured.
While this potential rheumatologic issue with silicone breast implants may never completely die in some minds, such a view does not currently hold up to scientific scrutiny. Investigations from around the worldwide on the topic provide overwhelming comfort for all women who have silicone breast implants or those that may be comtemplating breast implant surgery. While they are infrequent stories and internet websites in which patients report their ‘horrific’ experiences and alleged illnesses from breast implants surgery, confirmatory medical information is lacking to know the exact origin of their problems.
Dr Barry Eppley
Indianapolis, Indiana

 
							            